Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
ADMA Biologics Inc (ADMA) had Receiveable Turnover of 1.11 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$121.98M |
|
$34.22M |
|
$54.76M |
|
$67.23M |
|
$79.19M |
|
$42.80M |
|
$-2.70M |
|
$40.10M |
|
$40.10M |
|
$34.22M |
|
$34.22M |
|
$34.22M |
|
$34.22M |
|
$42.80M |
|
$44.98M |
|
241.49M |
|
248.61M |
|
$0.14 |
|
$0.14 |
|
| Balance Sheet Financials | |
$399.56M |
|
$57.50M |
|
$158.82M |
|
$558.38M |
|
$74.94M |
|
$82.70M |
|
$85.11M |
|
$160.06M |
|
$398.32M |
|
$394.27M |
|
$398.32M |
|
238.57M |
|
| Cash Flow Statement Financials | |
$1.46M |
|
$-7.25M |
|
$-7.08M |
|
$103.15M |
|
$90.28M |
|
$-12.86M |
|
$9.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.33 |
|
-- |
|
-- |
|
0.17 |
|
0.21 |
|
55.11% |
|
35.08% |
|
35.08% |
|
-- |
|
32.87% |
|
28.05% |
|
$-5.66M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
0.29 |
|
|
Receiveable Turnover |
1.11 |
80.96 |
|
8.59% |
|
8.68% |
|
6.13% |
|
7.11% |
|
$1.67 |
|
$-0.02 |
|
$0.01 |
|